Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults
- PMID: 1682395
- DOI: 10.1093/infdis/164.5.973
Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults
Abstract
One hundred five asymptomatic human immunodeficiency virus-seropositive adults were screened for measles antibody. Ages ranged from 21 to 59 years (mean, 35.7). CD4+ lymphocyte counts (range, 76-1137/mm3), percentage of CD4+ cells (6-42), CD4:CD8 ratio (0.08-1.3), measles antibody titers by EIA, and undocumented history of prior measles or immunization were obtained. Forty-six patients gave a history of measles but no immunization, 18 of immunization but no measles, 26 of immunization and measles, and 15 of neither measles nor vaccination. Only one patient (less than 1%) lacked levels of antibody considered protective. Neither the presence nor the level of antibody were predictable from patient age, history of measles or immunization, CD4+ lymphocyte count, percentage of CD4+ cells, or CD4:CD8 ratio. Nearly all subjects had antibody to measles, regardless of immunization or measles history. Whether these antibodies are truly protective is unknown.
Comment in
-
Measles antibodies in human immunodeficiency virus-infected adults.J Infect Dis. 1992 Mar;165(3):589. doi: 10.1093/infdis/165.3.589. J Infect Dis. 1992. PMID: 1538166 No abstract available.
Similar articles
-
Measles seroprevalence and vaccine response in HIV-infected adults.Vaccine. 1994 Oct;12(13):1222-4. doi: 10.1016/0264-410x(94)90247-x. Vaccine. 1994. PMID: 7839728 Clinical Trial.
-
Immune responses to measles immunization and the impacts on HIV-infected children.Southeast Asian J Trop Med Public Health. 2000 Dec;31(4):658-62. Southeast Asian J Trop Med Public Health. 2000. PMID: 11414407
-
Abnormalities of measles antibody response in human immunodeficiency virus type 1 (HIV-1) infection.J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Dec 15;10(5):540-8. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 8548333
-
Population immunity to measles in the United States, 1999.J Infect Dis. 2004 May 1;189 Suppl 1:S91-7. doi: 10.1086/377713. J Infect Dis. 2004. PMID: 15106096 Review.
-
Measles Seroprevalence and Vaccine Responses in Human Immunodeficiency Virus-infected Adolescents and Adults: A Systematic Review.Clin Infect Dis. 2019 Aug 16;69(5):836-844. doi: 10.1093/cid/ciy980. Clin Infect Dis. 2019. PMID: 30452621
Cited by
-
Long-term safety and serologic response to measles, mumps, and rubella vaccination in HIV-1 infected adults.Vaccine. 2011 Apr 5;29(16):2874-80. doi: 10.1016/j.vaccine.2011.02.013. Epub 2011 Feb 23. Vaccine. 2011. PMID: 21352938 Free PMC article.
-
Immunologic basis for revaccination of HIV-infected children receiving HAART.Future Virol. 2011 Jan 1;6(1):59-71. doi: 10.2217/fvl.10.75. Future Virol. 2011. PMID: 21339832 Free PMC article.
-
Bone marrow is a major site of long-term antibody production after acute viral infection.J Virol. 1995 Mar;69(3):1895-902. doi: 10.1128/JVI.69.3.1895-1902.1995. J Virol. 1995. PMID: 7853531 Free PMC article.
-
Serum antibodies to HIV-1 are produced post-measles virus infection: evidence for cross-reactivity with HLA.Clin Exp Immunol. 1998 Feb;111(2):251-6. doi: 10.1046/j.1365-2249.1998.00488.x. Clin Exp Immunol. 1998. PMID: 9486389 Free PMC article.
-
Decrease in Numbers of Naive and Resting B Cells in HIV-Infected Kenyan Adults Leads to a Proportional Increase in Total and Plasmodium falciparum-Specific Atypical Memory B Cells.J Immunol. 2017 Jun 15;198(12):4629-4638. doi: 10.4049/jimmunol.1600773. Epub 2017 May 19. J Immunol. 2017. PMID: 28526680 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials